CoChat
Sign Up
Cited by 43

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Connective Tissue Growth Factor Regulates Retinal Neovascularization through p53 Protein-dependent Transactivation of the Matrix Metalloproteinase (MMP)-2 Gene

Chintala, Hembindu, Liu, Haibo, Parmar, Rahul, Kamalska, Monika, Kim, Yoon Ji, Lovett, David, Grant, Maria B., Chaqour, Brahim·2012·Journal of Biological Chemistry
DOI 10.1074/jbc.m112.386565
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.386565

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CTGF has been shown to induce expression of specific MMPs in several pathophysiological conditions, including MMP-2 in retinal neovascularization and diabetic nephropathy, MMP-2 and MMP-3 in tumor metastasis, and MMP-3 and MMP-13 in osteoarthritis.

    “CTGF has been shown to induce the expression of specific MMPs in several pathophysiological conditions, including MMP-2 in both retinal neovascularization (33) and diabetic nephropathy (34), MMP-2 and MMP-3 in tumor metastasis (35), and MMP-3 and MMP-13 in osteoarthritis (36).”

    From Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia (2017) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 65

  1. Fleck, 2008, Pathogenesis of retinopathy of prematurity and possible preventive strategies, Early Hum. Dev., 84, 83, 10.1016/j.earlhumdev.2007.11.008 · DOI
  2. Kalka, 2000, Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization, Herz, 25, 611, 10.1007/PL00001974 · DOI
  3. Quinn, 2010, Retinopathy of prematurity: an epidemic in the making, Chin. Med. J., 123, 2929
  4. Sapieha, 2010, Retinopathy of prematurity. Understanding ischemic retinal vasculopathies at an extreme of life, J. Clin. Invest., 120, 3022, 10.1172/JCI42142 · DOI
  5. Li Calzi, 2010, EPCs and pathological angiogenesis. When good cells go bad, Microvasc. Res., 79, 207, 10.1016/j.mvr.2010.02.011 · DOI
  6. McVicar, 2010, Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy, PLoS. One, 5, e11870, 10.1371/journal.pone.0011870 · DOI
  7. Chen, 2009, Functions and mechanisms of action of CCN matricellular proteins, Int. J. Biochem. Cell Biol., 41, 771, 10.1016/j.biocel.2008.07.025 · DOI · Paper page
  8. Liu, 2008, Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes, Endocrinology, 149, 1666, 10.1210/en.2007-1415 · DOI
  9. Chaqour, 2006, Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-κB activation, J. Biol. Chem., 281, 20608, 10.1074/jbc.M600214200 · DOI
  10. Kireeva, 1997, Cyr61 and Fisp12 are both ECM-associated signaling molecules. Activities, metabolism, and localization during development, Exp. Cell Res., 233, 63, 10.1006/excr.1997.3548 · DOI
  11. Twigg, 2001, Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus, Endocrinology, 142, 1760, 10.1210/endo.142.5.8141 · DOI
  12. Abreu, 2002, Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-β, Nat. Cell Biol., 4, 599, 10.1038/ncb826 · DOI
  13. Chintalapudi, 2008, Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells, Carcinogenesis, 29, 696, 10.1093/carcin/bgn019 · DOI
  14. Crean, 2006, Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1), FASEB J., 20, 1712, 10.1096/fj.05-5010fje · DOI
  15. Hasan, 2011, The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy, J. Biol. Chem., 286, 9542, 10.1074/jbc.M110.198689 · DOI · Paper page
  16. Katsube, 2009, Role of CCN, a vertebrate-specific gene family, in development, Dev. Growth Differ., 51, 55, 10.1111/j.1440-169X.2009.01077.x · DOI
  17. Kubota, 2007, CCN family proteins and angiogenesis. From embryo to adulthood, Angiogenesis, 10, 1, 10.1007/s10456-006-9058-5 · DOI
  18. Leask, 2009, Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?, J. Cell Commun. Signal., 3, 89, 10.1007/s12079-009-0037-7 · DOI
  19. Arnott, 2011, The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis, Crit. Rev. Eukaryot. Gene Expr., 21, 43, 10.1615/CritRevEukarGeneExpr.v21.i1.40 · DOI
  20. Ivkovic, 2003, Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development, Development, 130, 2779, 10.1242/dev.00505 · DOI
  21. Doherty, 2010, A mouse strain where basal connective tissue growth factor gene expression can be switched from low to high, PLoS ONE, 5, e12909, 10.1371/journal.pone.0012909 · DOI
  22. Babic, 1999, Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αvβ3, promotes endothelial cell survival, and induces angiogenesis in vivo, Mol. Cell. Biol., 19, 2958, 10.1128/MCB.19.4.2958 · DOI
  23. Kuiper, 2007, Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice, J. Histochem. Cytochem., 55, 1139, 10.1369/jhc.7A7258.2007 · DOI
  24. Shimo, 1999, Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo, J. Biochem., 126, 137, 10.1093/oxfordjournals.jbchem.a022414 · DOI
  25. Kuiper, 2008, Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice, J. Histochem. Cytochem., 56, 785, 10.1369/jhc.2008.950980 · DOI
  26. Garcia Abreu, 2002, Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems, Gene, 287, 39, 10.1016/S0378-1119(01)00827-7 · DOI
  27. Hinton, 2004, Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy, Diabetes Care, 27, 758, 10.2337/diacare.27.3.758 · DOI
  28. Grotendorst, 2005, Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation, FASEB J., 19, 729, 10.1096/fj.04-3217com · DOI
  29. Yoon, 2010, The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis, J. Mol. Cell. Cardiol., 49, 294, 10.1016/j.yjmcc.2010.04.010 · DOI
  30. Smith, 1994, Oxygen-induced retinopathy in the mouse, Invest. Ophthalmol. Vis. Sci., 35, 101
  31. Harendza, 1995, Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells, J. Biol. Chem., 270, 18786, 10.1074/jbc.270.32.18786 · DOI
  32. Pi, 2011, Role of connective tissue growth factor in the retinal vasculature during development and ischemia, Invest. Ophthalmol. Vis. Sci., 52, 8701, 10.1167/iovs.11-7870 · DOI
  33. Gauthier, 2005, Brain-derived neurotrophic factor gene delivery to Muller glia preserves structure and function of light-damaged photoreceptors, Invest. Ophthalmol. Vis. Sci., 46, 3383, 10.1167/iovs.05-0362 · DOI
  34. Kordower, 1999, Lentiviral gene transfer to the nonhuman primate brain, Exp. Neurol., 160, 1, 10.1006/exnr.1999.7178 · DOI
  35. Apte, 2010, Regulation of angiogenesis by macrophages, Adv. Exp. Med. Biol., 664, 15, 10.1007/978-1-4419-1399-9_2 · DOI
  36. Kociok, 2006, Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice, Invest. Ophthalmol. Vis. Sci., 47, 5057, 10.1167/iovs.06-0407 · DOI
  37. Weidemann, 2010, Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina, Glia, 58, 1177, 10.1002/glia.20997 · DOI
  38. Vinores, 2007, TNF-α is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage, J. Neuroimmunol., 182, 73, 10.1016/j.jneuroim.2006.09.015 · DOI
  39. Kowluru, 2009, Oxidative stress and the development of diabetic retinopathy. Contributory role of matrix metalloproteinase-2, Free Radic. Biol. Med., 46, 1677, 10.1016/j.freeradbiomed.2009.03.024 · DOI
  40. Sternlicht, 2001, How matrix metalloproteinases regulate cell behavior, Annu. Rev. Cell Dev. Biol., 17, 463, 10.1146/annurev.cellbio.17.1.463 · DOI · Paper page
  41. Tronc, 2000, Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO, Arterioscler. Thromb. Vasc. Biol., 20, E120, 10.1161/01.ATV.20.12.e120 · DOI
  42. Bian, 1997, Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter, Mol. Cell. Biol., 17, 6330, 10.1128/MCB.17.11.6330 · DOI
  43. Di, Giovanni, 2012, p53-Dependent pathways in neurite outgrowth and axonal regeneration, Cell Tissue Res., 349, 87, 10.1007/s00441-011-1292-5 · DOI
  44. Hall-Glenn, 2012, CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis, PLoS One, 7, e30562, 10.1371/journal.pone.0030562 · DOI
  45. Jun, 2011, Taking aim at the extracellular matrix. CCN proteins as emerging therapeutic targets, Nat. Rev. Drug Discov., 10, 945, 10.1038/nrd3599 · DOI · Paper page
  46. Sakimoto, 2012, A role for endothelial cells in promoting the maturation of astrocytes through the apelin/APJ system in mice, Development, 139, 1327, 10.1242/dev.072330 · DOI
  47. Scott, 2010, Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature, PLoS One, 5, e11863, 10.1371/journal.pone.0011863 · DOI
  48. Watson, 2012, Dynamics of angiogenesis during murine retinal development: a coupled in vivoin silico study, J. R. Soc. Interface, 9, 2351, 10.1098/rsif.2012.0067 · DOI
  49. Suzuma, 2000, Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells, J. Biol. Chem., 275, 40725, 10.1074/jbc.M006509200 · DOI
  50. Wunderlich, 2000, Regulation of connective tissue growth factor gene expression in retinal vascular endothelial cells by angiogenic growth factors, Graefes Arch. Clin. Exp. Ophthalmol., 238, 910, 10.1007/s004170000199 · DOI
  51. Samarin, 2010, FoxO proteins mediate hypoxic induction of connective tissue growth factor in endothelial cells, J. Biol. Chem., 285, 4328, 10.1074/jbc.M109.049650 · DOI
  52. He, 2008, Connective tissue growth factor as a mediator of intraocular fibrosis, Invest. Ophthalmol. Vis. Sci., 49, 4078, 10.1167/iovs.07-1302 · DOI
  53. Inoki, 2002, Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis, FASEB J., 16, 219, 10.1096/fj.01-0332fje · DOI
  54. Kuiper, 2008, The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy, PLoS ONE, 3, e2675, 10.1371/journal.pone.0002675 · DOI
  55. Barnett, 2007, Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR, Invest. Ophthalmol. Vis. Sci., 48, 907, 10.1167/iovs.06-0082 · DOI
  56. Mohammad, 2010, Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction, Lab. Invest., 90, 1365, 10.1038/labinvest.2010.89 · DOI
  57. Suofu, 2012, Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion, Neuroscience, 212, 180, 10.1016/j.neuroscience.2012.03.036 · DOI
  58. Bergers, 2000, Extrinsic regulators of epithelial tumor progression. Metalloproteinases, Curr. Opin. Genet. Dev., 10, 120, 10.1016/S0959-437X(99)00043-X · DOI
  59. Chang, 2007, IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development, Proc. Natl. Acad. Sci. U.S.A., 104, 10595, 10.1073/pnas.0702072104 · DOI
  60. Ishida, 2003, Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease, Nat. Med., 9, 781, 10.1038/nm877 · DOI
  61. Dean, 2007, Mol. Cell. Biol., 27, 8454, 10.1128/MCB.00821-07 · DOI
  62. Bergman, 2003, A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers, Biochem. J., 369, 485, 10.1042/bj20020707 · DOI
  63. Lee, 2005, Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia, Proc. Natl. Acad. Sci. U.S.A., 102, 16345, 10.1073/pnas.0508085102 · DOI
  64. Yu, 1999, Identification and classification of p53-regulated genes, Proc. Natl. Acad. Sci. U.S.A., 96, 14517, 10.1073/pnas.96.25.14517 · DOI
  65. Lee, 2003, Thrombospondin-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells, J. Vasc. Surg., 38, 147, 10.1016/S0741-5214(02)75468-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Chintala, H., Liu, H., Parmar, R., Kamalska, M., Kim, Y. J., Lovett, D., Grant, M. B., & Chaqour, B.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-11
Volume
287
Issue
48
Pages
40570-40585
ISSN
0021-9258
DOI
10.1074/jbc.m112.386565
Cited by
43
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review